Recombinant erythropoietin alfa preparations in injectable form for stimulating erythropoiesis in anemia treatment. Produced by biotechnology companies for procurement by healthcare facilities in oncology, nephrology, and hematology departments for subcutaneous or intravenous delivery to patients.